O'Shaughnessy Asset Management, LLC Denali Therapeutics Inc. Transaction History

O'Shaughnessy Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$29.0 - $47.27 $193,923 - $316,094	-6,687 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$42.59 - $55.02 $809 - $1,045	-19 Reduced 0.28%	6,687 $298,000
Q3 2021 Nov 10, 2021	SELL	$48.48 - $78.23 $16,919 - $27,302	-349 Reduced 4.95%	6,706 $339,000
Q2 2021 Aug 09, 2021	SELL	$50.3 - $78.44 $42,151 - $65,732	-838 Reduced 10.62%	7,055 $553,000
Q4 2020 Feb 11, 2021	BUY	$36.89 - $93.56 $290,250 - $736,130	7,868 Added 31472.0%	7,893 $661,000
Q2 2020 Aug 13, 2020	BUY	$16.01 - $28.82 $400 - $720	25 New	25 $1,000

228

120M

60.6K

48.4K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $3.31B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.